Gemini Trains will order a fleet of Siemens Velaro Novo trains if it is able to start running international services. It is one of four firms looking to run open access services between London St ...
Health-care companies rose as traders rotated back into a sector that had fallen out of favor. Shares of insurers such as Humana and UnitedHealth Group added to recent gains following weak performance ...
Mounjaro recorded sales of Rs 85 crore in September. Analysts say user-friendly pen formulation helped build the momentum, expected to get a further boost from GST cuts ...
Investor's Business Daily on MSN
Hims Stock, Up 138%: IBD Stock Of The Day Makes Another Breakout Run
Hims & Hers HealthHIMS is Wednesday's IBD Stock Of The Day. After returning to the IBD 50, Hims stock is making a second attempt at a breakout since late July.The telehealth giant announced its ...
Add Sam's Club to the list of retail pharmacy options for consumers who want to buy the pricey weight-loss drugs Ozempic and Wegovy. Sam's Club pharmacies now sell Novo Nordisk's Wegovy and Ozempic ...
Moderately bullish activity in Novo Nordisk (NVO), with shares up 68c, or 1.16%, near $59.70. Options volume relatively light with 42k contracts traded and calls leading puts for a put/call ratio of 0 ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Costco members with a valid prescription can pay the $499 self-pay price and insurance coverage will vary by plan for a 4-week supply of Ozempic or Wegovy. HealthDay News — Costco shoppers will be ...
A medical expert has made a case for taking smaller GLP-1 injections, despite manufacturers warning against the practice.
Pfizer has re-entered the obesity drug sector by acquiring Metsera, Inc., having successfully outmaneuvered six other bidders. Click to read why PFE is a Buy.
The company, Novo Nordisk, said Friday that prescription-only injectable pens for both drugs will be sold at more than 500 Costco pharmacies in the United States. Executive members and people with ...
Shares of Costco (NASDAQ:COST) have finally entered correction territory, dipping by close to 14% from its all-time highs. Indeed, buying the dip in the beloved bulk-buy retailer has paid off in a big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results